"Masimo secures FDA approval for OIRD detection on wearable patient monitor" was originally created and published by Medical ...

Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring ...

The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.

Danaher Corporation DHR has completed the acquisition of Masimo Corp. for $180 per share in cash. The transaction was valued ...

Some Pixel Watch owners say SpO2 and skin temperature tracking stopped working after a recent Fitbit update. Google and Fitbit have acknowledged the permission reset issue and say work is underway to ...

Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced ...

NICU Study Adds to the Evidence Demonstrating SET®’s Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance Across Skin Pigmentation Categories or Race ...

Masimo Corp. today reported study data showing that its pulse oximetry technology accurately monitored hospitalized newborns of all skin tones without dangerous drops in blood oxygen. The findings ...

Apple can keep selling Apple Watches with its redesigned blood oxygen feature in the US after the ITC declined to revive Masimo’s ban. Apple has secured a significant victory in its years-long dispute ...

Apple has been embroiled in a six-year legal battle over one of its Apple Watch health apps. The end may finally be in sight, and here's what Apple has to say about it. Anna Gragert Senior Editor, ...